RegeneRx Biopharmaceuticals, Inc. Release: Ophthalmology Times Publishes Article on RGN-259 and Corneal Wound Healing

BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today an article entitled “Experimental drug promotes healing in patients with non-healing corneal ulcers,” was published in Ophthalmology Times, Vol. 34, No. 6, Mar 2009. The article describes the data generated by Dr. Steven Dunn, a corneal specialist in Detroit, Michigan, in patients with neurotrophic keratitis caused primarily by the herpes zoster virus and previously reported by the Company. The article may be accessed by pasting the following web address into your web browser:
MORE ON THIS TOPIC